Third Amended and Restated Security AgreementSecurity Agreement • November 8th, 2017 • MusclePharm Corp • Pharmaceutical preparations • New York
This Third Amended and Restated Security Agreement (this “Agreement”), dated as of November 3, 2017, is entered into between Ryan Drexler, an individual (“Grantee”), and MusclePharm Corporation, a Nevada corporation, as grantor (“Grantor”).
ContractNote Agreement • November 8th, 2017 • MusclePharm Corp • Pharmaceutical preparations • New York
THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.
RESTRUCTURING AGREEMENTRestructuring Agreement • November 8th, 2017 • MusclePharm Corp • Pharmaceutical preparations • New York
This Restructuring Agreement (the “Agreement”) is made as of November 3, 2017, by and between Ryan Drexler, an individual (“Drexler”) and MusclePharm Corporation, a Nevada corporation (the “Company”).
SUBORDINATION AGREEMENTSubordination Agreement • November 8th, 2017 • MusclePharm Corp • Pharmaceutical preparations • North Carolina
The undersigned, Ryan Drexler with an address at (hereinafter referred to as the "Creditor"), represents that MusclePharm Corporation and/or Canada MusclePharm Enterprises Corp. (hereinafter collectively referred to as the "Borrower"), is indebted to the Creditor as follows:
FIRST AMENDMENT TO SUBORDINATION AGREEMENTSubordination Agreement • November 8th, 2017 • MusclePharm Corp • Pharmaceutical preparations
This First Amendment to Subordination Agreement (this “Amendment”) is made as of November 3, 2017, by and between (a) CROSSROADS FINANCIAL GROUP, LLC, a North Carolina limited liability company (the “Lender”) and (b) Ryan Drexler, an individual (the “Creditor”).
